North America Blood Collection Devices Market (2025-2030)
The North America Blood Collection Devices Market was valued at $874.7 Million in 2025 and projected to reach to $1203.6 Million by 2030, representing a compound annual growth rate of 6.6%. The North America blood collection devices market is poised for steady expansion through 2030, supported by aging demographics, increased prevalence of chronic diseases, and heightened focus on patient and healthcare worker safety.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Blood Collection Devices Market Trends and Insights
- North America's advanced healthcare infrastructure, high diagnostic testing volumes, and strong adoption of safety-engineered devices drive market expansion.
- In North America, regulatory compliance with OSHA bloodborne pathogen standards and increasing demand for phlebotomy automation support sustained market growth through 2030. North America's blood collection devices sector benefits from established clinical laboratory networks and rising prevalence of chronic diseases requiring frequent blood testing.
- North America's market is characterized by preference for integrated collection systems and needle safety innovations.
- The region's healthcare spending and emphasis on occupational safety position North America as a mature yet growing market segment within the global blood collection devices industry..
Key Market Statistics
- CAGR (2025-2030) 6.6% CAGR
- Market Size, 2025 ~USD 874.7 Million
- Forecast, 2030 ~USD 1203.6 Million
- Geography North America
North America Blood Collection Devices Market Overview
Market Valuation & Growth :
North America's blood collection devices market is valued at $874.7 million in 2025, with a projected CAGR of 6.6% through 2030, reaching $1,203.6 million. This growth outpaces many global regions due to sustained healthcare investments and diagnostic demand.
Safety-Engineered Device Adoption :
Strong regulatory compliance with OSHA standards drives widespread adoption of safety-engineered blood collection devices across North American healthcare facilities, reducing needlestick injuries and occupational exposure incidents.
Advanced Healthcare Infrastructure :
North America's sophisticated healthcare system, including extensive hospital networks, diagnostic laboratories, and point-of-care testing centers, creates consistent demand for high-quality blood collection devices and supplies.
High Diagnostic Testing Volumes :
Elevated diagnostic testing rates across the US and Canada, driven by preventive care initiatives and chronic disease management programs, sustain robust demand for blood collection devices in clinical and laboratory settings.
North America Blood Collection Devices Market Dynamics
- Regulatory mandates requiring safety-engineered devices continue to reshape procurement decisions across hospitals, clinics, and diagnostic centers.
- Investment in automation and integrated collection systems further accelerates market growth.
- The region's mature healthcare infrastructure and high reimbursement rates enable adoption of advanced technologies, positioning North America as a premium market segment.
- Competitive pressures and consolidation among device manufacturers will drive innovation in needle design, collection tube materials, and integrated diagnostic solutions..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- North America's blood collection devices market will grow from $874.7M (2025) to $1,203.6M (2030) at a 6.6% CAGR.
- North America's regulatory environment and OSHA compliance requirements drive adoption of safety-engineered collection devices.
- North America's mature healthcare infrastructure and high diagnostic testing volumes support consistent market demand.
- North America's preference for integrated and automated phlebotomy solutions differentiates the region from emerging markets.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
North America Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
Target Audience
- Medical Device Manufacturers : Manufacturers need North America-specific market data to develop compliant products, optimize pricing strategies, and identify distribution partnerships aligned with regional regulatory requirements and healthcare procurement standards.
- Healthcare Facility Administrators : Hospital and clinic leaders require market insights to evaluate device options, benchmark procurement costs, assess safety compliance solutions, and plan capital budgets for blood collection equipment upgrades.
- Diagnostic Laboratory Operators : Laboratory managers need detailed market analysis to select optimal collection devices, manage supplier relationships, ensure regulatory compliance, and optimize operational efficiency in high-volume testing environments.
- Healthcare Investors & Consultants : Investment firms and management consultants require regional market forecasts, competitive intelligence, and growth drivers to evaluate acquisition targets, assess portfolio companies, and identify emerging opportunities in medical devices.
- Regulatory & Compliance Officers : Compliance professionals need North America-specific regulatory intelligence, OSHA requirements, and safety standards to ensure organizational adherence, guide procurement decisions, and mitigate occupational health risks.
Key Companies in the North America Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1070.7 Million |
| Canada | USD 395 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into US and Canadian market dynamics separately, including country-specific regulatory requirements, reimbursement structures, and competitive landscapes essential for targeted market entry strategies.
- Safety Compliance Intelligence : Understand OSHA regulatory compliance requirements and safety-engineered device mandates specific to North America, enabling manufacturers to align product development with regional standards and procurement criteria.
- Growth Opportunity Identification : Identify high-growth segments within North America's $1.2 billion market by 2030, including emerging technologies, underserved healthcare settings, and expansion opportunities in diagnostic testing infrastructure.
- Competitive Positioning : Benchmark your organization against regional competitors with market share analysis, pricing strategies, and distribution channel insights specific to North American healthcare procurement practices.
- Investment & Expansion Planning : Support capital allocation decisions and market expansion strategies with validated forecasts, demographic trends, and healthcare utilization patterns driving blood collection device demand across North America.
Frequently asked questions
What is the market size of blood collection devices in North America in 2025?
North America's blood collection devices market is estimated at $874.7 million in 2025.
What is the projected market size for North America by 2030?
North America's blood collection devices market is forecasted to reach $1,203.6 million by 2030.
What is the CAGR for North America's blood collection devices market?
North America's blood collection devices market is expected to grow at a compound annual growth rate of 6.6% from 2025 to 2030.
What factors drive growth in North America's blood collection devices market?
North America's market growth is driven by advanced healthcare infrastructure, regulatory compliance requirements, high diagnostic testing volumes, and adoption of safety-engineered devices.
How does North America's market compare to global trends?
North America's 6.6% CAGR is slightly below the global average of 7.4%, reflecting the region's mature market status with steady, established demand patterns.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
